RecruitingNot ApplicableNCT06074744

Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty

Subsartorial Saphenous Nerve Block (SSNB) Versus Femoral Nerve Block (FNB) in Primary Total Knee Arthroplasty (TKA) Combined With Infiltration Between Popliteal Artery and Capsule of the Knee (IPACK) - Where Are the Benefits?


Sponsor

Luzerner Kantonsspital

Enrollment

144 participants

Start Date

Nov 30, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare two different types of nerve blocks in patients undergoing surgery for primary Total Knee Arthroplasty. The main question aim to answer is: \- is there a benefit in functional muscle power output of the leg? Participants will be randomized into either the intervention group or the control group and: * receive Subsartorial Saphenous Nerve Block (SSNB) + IPACK in intervention group (group 1) * receive Femoral Nerve Block (FNB) + IPACK in control group (group 2) Researchers will compare the 2 groups to see if there are differences in : * functional muscle power output of the leg? * muscle function, mobility, clinical and radiological results, ROM, pain control (NRS), opioid consumption, length of hospital stay, patient satisfaction, mobility, reduction of costs?


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • age > 18yrs
  • primary TKA
  • BMI 35kg/m2 or less
  • able to give informed consent as documented by signature
  • clinical history without any contraindications for the planned intervention

Exclusion Criteria8

  • age < 18 years
  • revision-TKA
  • BMI >35kg/m2
  • absent contact information
  • inability or contraindications to undergo the investigated intervention (TKA, FNB, SSNB), - clinically significant concomitant diseases
  • pregnancy
  • inability to follow the procedures and follow-up procedures of the study (e.g. due to language problems, psychological disorders, dementia, living abroad, etc.
  • withdrawal from the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSSNB + IPACK

already included in arm/group description

OTHERFNB + IPACK

already included in arm/group description


Locations(1)

Luzerner Kantonsspital

Lucerne, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06074744


Related Trials